Kojima S, Omori M
Research Institute, Sumitomo Pharmaceuticals Co., Osaka, Japan.
FEBS Lett. 1992 Jun 8;304(1):57-60. doi: 10.1016/0014-5793(92)80588-8.
The beta-amyloid protein (beta-AP) derived from a beta-amyloid protein precursor (APP) is a hallmark of Alzheimer's disease. The abundant generation of beta-AP suggests the abnormal processing of APP, but the molecular mechanism remains unclear. The main APP-processing enzyme was purified from the rat brain and identified to be a macropain-like multicatalytic proteinase. The purified enzyme cleaved the Gln15-Lys16 bond of beta-AP, but altered to cleave at the N-terminus of beta-AP to release the extracellular domain of beta-AP in the presence of Ca2+. These findings suggest that the functional change in this multicatalytic proteinase may result in abnormal processing of APP.
源自β-淀粉样蛋白前体(APP)的β-淀粉样蛋白(β-AP)是阿尔茨海默病的一个标志。β-AP的大量产生提示APP的加工异常,但分子机制仍不清楚。主要的APP加工酶从大鼠脑中纯化出来,被鉴定为一种类巨肽酶多催化蛋白酶。纯化的酶切割β-AP的Gln15-Lys16键,但在Ca2+存在时改变为在β-AP的N端切割以释放β-AP的细胞外结构域。这些发现提示这种多催化蛋白酶的功能改变可能导致APP的加工异常。